Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Opiant Pharmaceuticals Inc (OPNT)  
$20.65 0.00 (0.00%) as of 4:30 Wed 3/1


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 4,260,000
Market Cap: 87.97(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $20.65 - $20.65
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Opiant Pharmaceuticals is a pharmaceutical company developing medicines for addictions and drug overdose. Co.'s longer term pipeline includes medicines in development for Alcohol Use Disorder, Opioid Use Disorder, and Acute Cannabinoid Overdose. Co. is also pursuing other treatment opportunities within the addiction and drug overdose field. Co. has developed NARCAN® (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdose.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 42,039
Total Buy Value $0 $0 $0 $535,574
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 6
Total Shares Sold 0 0 0 73,613
Total Sell Value $0 $0 $0 $1,050,459
Total People Sold 0 0 0 7
Total Sell Transactions 0 0 0 28
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 257
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Otoole David D Chief Financial Officer   •       –      –    2023-03-02 4 D $20.00 $724,960 D/D (36,248) 0     -
   Otoole David D Chief Financial Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000     -
   Skolnick Phil Chief Scientific Officer   •       –      –    2023-03-02 4 D $20.00 $470,960 D/D (23,548) 0     -
   Skolnick Phil Chief Scientific Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000     -
   Gorman Brian General Counsel   –       –      –    2023-03-02 4 D $20.00 $679,800 D/D (33,990) 0     -
   Gorman Brian General Counsel   –       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000     -
   Ellison Mark Jason Heath Chief Development Officer   •       –      –    2023-03-02 4 D $20.00 $415,020 D/D (20,751) 0     -
   Ellison Mark Jason Heath Chief Development Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000     -
   Ellison Mark Jason Heath Chief Development Officer   •       –      –    2023-03-02 4 D $20.00 $193,600 I/I (9,680) 0     -
   Lorianne Masuoka K. Director   –       •      –    2023-03-02 4 D $20.00 $80,000 D/D (4,000) 0     -
   Silver Gabrielle Alison Director   –       •      –    2023-03-02 4 D $20.00 $466,860 D/D (23,343) 0     -
   Sinclair Michael Director   –       •       •   2023-03-02 4 D $20.00 $1,254,400 D/D (62,720) 0     -
   Sinclair Michael Director   –       •       •   2023-03-02 4 D $20.00 $549,000 I/I (27,450) 0     -
   Crystal Roger Chief Executive Officer   •       •       •   2023-03-02 4 D $20.00 $1,640,120 D/D (82,006) 0     -
   Crystal Roger Chief Executive Officer   •       •       •   2023-03-02 4 A $0.00 $0 D/D 6,667 6,667     -
   Crystal Roger Chief Executive Officer   •       •       •   2023-03-02 4 D $20.00 $102,000 D/D (5,100) 0     -
   Macdougall Ann L. Director   –       •      –    2023-03-02 4 D $20.00 $563,580 D/D (28,179) 0     -
   Thomas Thomas T. Director   –       •      –    2023-03-02 4 D $20.00 $247,500 D/D (12,375) 0     -
   Collard Craig A Director   –       •      –    2023-03-02 4 D $20.00 $1,116,440 D/D (55,822) 0     -
   Ruth Matthew R. Chief Commercial Officer   •       –      –    2023-03-02 4 D $20.00 $638,320 D/D (31,916) 0     -
   Ruth Matthew R. Chief Commercial Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 2,000 2,000     -
   Daly Richard J Director   –       •      –    2023-03-02 4 D $20.00 $156,000 D/D (7,800) 0     -
   Crystal Roger Chief Executive Officer   •       •       •   2023-01-27 4 S $20.26 $27,513 D/D (1,358) 75,339 -2%     
   Otoole David D Chief Financial Officer   •       –      –    2023-01-27 4 S $20.26 $10,961 D/D (541) 34,248 -2%     
   Skolnick Phil Chief Scientific Officer   •       –      –    2023-01-27 4 S $20.26 $9,725 D/D (480) 21,548 -2%     

  257 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed